AAP |
American
Academy of Pediatrics |
AAFP |
American
Academy of Family Physicians |
AAHP |
American
Association of Health Plans |
ACASA |
Adult
Clinic Assessment Software Application |
ACIP |
Advisory
Committee on Immunization Practices |
ACOG |
American
College of Obstetricians and Gynecologists |
AFIX |
Assessment,
Feedback and Incentives Exchange |
AIDS |
Acquired
Immune Deficiency Syndrome |
AIRA |
American
Immunization Registry Association |
AKC |
All
Kids Count |
ASD |
Autism-spectrum
disorder |
ASTPHLD |
Association
of State and Territorial Public Health
Laboratory Directors |
ATPM |
Association
of Teachers of Preventive Medicine |
ATSDR |
Agency
for Toxic Substances and Disease Registry |
BCG |
Bacillus
of Calmette and Guérin (tuberculosis
vaccine) |
BSE |
Bovine
spongiform encephalopathy |
CASA |
Clinic
Assessment Software Application |
CBER |
Center
for Biologics Evaluation and Research (FDA) |
CDC |
Centers
for Disease Control and Prevention |
CF |
Complement
fixation |
CII |
Childhood
Immunization Initiative |
CIRSET |
Committee
on Immunization Registry Standards
and Electronic Transactions (an
organization that is no longer in existence
as May 2006) |
CISA |
Clinical
Immunization Safety Assessment Centers |
CJD |
Creutzfeldt-Jakob
disease |
CMV |
Cytomegalovirus |
COID |
Committee
on Infectious Diseases (AAP) |
CPHA |
Commission
on Professional and Hospital Activities |
CRS |
Congenital
rubella syndrome |
CSF |
Cerebrospinal
fluid |
CSTE |
Council
of State and Territorial Epidemiologists |
CVID |
Common
variable immune deficiency |
DAT |
Diphtheria
antitoxin |
DFA |
Direct
fluorescent antibody |
DHHS |
Department
of Health and Human Services |
DMD |
Data
Management Division |
DoD |
Department
of Defense |
DPT |
Replaced
by use of DTP. See DTP for description. |
DRSP |
Drug-resistant
Streptococcus pneumonia |
DT |
Diphtheria
and tetanus toxoids, pediatric formulation,
for children 6 weeks to 7 years of age |
DTP |
Diphtheria
and tetanus toxoids and whole-cell pertussis
vaccine |
DTaP |
Diphtheria
and tetanus toxoids and acellular pertussis
vaccine |
EBV |
Epstein-Barr
virus |
ECBT |
Every
Child By Two |
EIA |
Enzyme
immunoassay |
ELISA |
Enzyme-linked
immunosorbent assay |
ELR |
Electronic
laboratory reporting |
EPA |
Environmental
Protection Agency |
EPO |
Epidemiology
Program Office |
ESD |
Epidemiology
and Surveillance Division |
FAMA |
Fluorescent
antibody to membrane antigen |
FDA |
Food
and Drug Administration |
GBS |
Guillain-Barre
Syndrome |
HA |
Hemagglutinin |
HAV |
Hepatitis
A virus |
HBcAg |
Hepatitis
B core antigen |
HBIG |
Hepatitis
B immune globulin |
HBeAg |
Hepatitis
B e antigen |
HBsAg |
Hepatitis
B surface antigen |
HBV |
Hepatitis
B virus |
HCFA |
Healthcare
Financing Administration |
HCV |
Hepatitis
C virus |
HDV |
Hepatitis
D virus (delta agent) |
HHE |
Hypotonic,
Hyporesponsive Episode |
HI |
Hemagglutination
inhibition |
Hi |
Haemophilus
influenza |
Hib |
Haemophilus
influenza type b |
HICPAC |
Healthcare
and Infection Control Practices Advisory
Committee |
HMO |
Health
Maintenance Organization |
HRSA |
Health
Resources and Services Administration |
HSCT |
Hematopoietic
Stem Cell Transplant |
IAC |
Immunization
Action Coalition |
IAVG |
Interagency
Vaccine Group |
IBD |
Inflammatory
Bowel Disease |
IDSA |
Infectious
Disease Society of America |
IFA |
Indirect
fluorescent antibody |
IG |
Immune
globulin |
IgE |
Immunoglobulin
E |
IL-4 |
Interleukin
4 |
IL-10 |
Interleukin
10 |
IND |
Investigational
new drug |
IOM |
Institute
of Medicine |
IPV |
Inactivated
poliovirus vaccine |
IRB |
Institutional
Review Board |
IRC |
Immunization
Registry Conference |
ISD |
Immunization
Services Division |
LA |
Latex
agglutination |
LAIV |
Live,
Attenuated Influenza Vaccine |
LIS |
Laboratory
information system |
MCV |
Measles-containing
vaccines |
MMR |
Measles-mumps-rubella
vaccine |
MMWR |
Morbidity
and Mortality Weekly Report |
MR |
Measles-rubella
vaccine |
MS |
Multiple
Sclerosis |
MSAEFI |
Monitoring
System for Adverse Events Following Immunization |
NA |
Neuraminidase |
NACIC |
National
Advisory Committee of Immunization in Canada |
NCCLS |
National
Committee for Clinical Laboratory Standards |
NCHS |
National
Center for Health Statistics |
NCID |
National
Center for Infectious Diseases |
NCRSR |
National
Congenital Rubella Syndrome Registry |
NCVIA |
National
Childhood Vaccine Injury Act of 1986 |
NETSS |
National
Electronic Telecommunications System for
Surveillance |
NHANES |
National
Health and Nutrition Examination Survey |
NHIS |
National
Health Interview Survey |
NIC |
National
Immunization Conference |
NIH |
National
Institutes of Health |
NIIW |
National
Infant Immunization Week |
NIP |
National
Immunization Program |
NMA |
National
Medical Association |
NNDSS |
National
Notifiable Diseases Surveillance System |
NNii |
National
Network for Immunization Information |
NPI |
National
Partnership for Immunization |
NVAC |
National
Vaccine Advisory Committee |
nvCJD |
new
variant Creutzfeldt-Jakob disease |
NVICP |
National
Vaccine Injury Compensation Program |
NVPO |
National
Vaccine Program Office |
OPV |
Oral
poliovirus vaccine |
P&I |
Pneumonia
and influenza |
PAHO |
Pan
American Health Organization |
PCR |
Polymerase
chain reaction |
PCV7 |
Pneumococcal
Conjugate Vaccine (7-valent) |
PFP |
Partnership
for Prevention |
PHA |
Passive
hemagglutination |
PHF |
Public
Health Foundation |
PHLIS |
Public
Health Laboratory Information System |
PHPPO |
Public
Health Practice Program Office |
PHS |
Public
Health Service |
PHTN |
Public
Health Training Network |
PMIRWG |
Program
Managers Immunization Registry Work Group |
PPD |
Purified
protein derivative |
PPV23 |
Pneumococcal
Polysaccharide Vaccine (23-valent) |
PRMA |
Pharmaceutical
Research and Manufacturers of America |
RASH |
Rapid
Surveillance Helper |
RET |
Reportable
Events Table |
RIA |
Radioimmunoassay |
RNA |
Ribonucleic
acid |
RSD |
Residual
Seizure Disorder |
RST |
Registry
Support Team |
SCID |
Severe
combined immune deficiency |
SIDS |
Sudden
Infant Death Syndrome |
SHC |
State
health coordinator |
SPSS |
Supplementary
Pertussis Surveillance System |
SSPE |
Subacute,
sclerosing panencephalitis |
Td |
Tetanus
and diphtheria toxoids, adult formulation,
for persons 7 years and older |
Tdap |
Adolescent/adult
tetanus, diphtheria, and pertussis
(whooping cough) vaccine |
TIG |
Tetanus
immune globulin |
TT |
Tetanus
toxoid |
TWG |
Technical
Working Group (Immunization Registry) |
VAE |
Vaccine
adverse event |
VAERS |
Vaccine
Adverse Event Reporting System |
VAPP |
Vaccine-associated
paralytic poliomyelitis |
vCJD |
Variant
Creutzfeldt-Jakob disease |
VFC |
Vaccines
for Children |
VHC |
Vaccine
Health Centers |
VHSP |
Viral
Hepatitis Surveillance Program |
VICP |
Vaccine
Injury Compensation Program |
VIG |
Vaccinia immune globulin |
VIS |
Vaccine
Information Statement |
VISI |
Vaccine
Identification Standards Initiative |
VPD |
Vaccine-preventable
disease |
VRBPAC |
Vaccines
and Related Biological Products Advisory
Committee (CBER) |
VSD |
Vaccine
Safety Datalink project |
VZIG |
Varicella-zoster
immune globulin |
VZV |
Varicella-zoster
virus |
WBC |
White
blood-cell count |
WHO |
World
Health Organization |